San Diego, August 5, 2015 — GenomeDx Biosciences announced that it will present at the Wedbush PacGrow Healthcare Conference at 9:45 a.m. ET on Wednesday, August 12, in New York. Dave Matthews, CFO of GenomeDx, will provide an update about the company’s Decipher® test and an overview of the Company’s pipeline. About Decipher® The Decipher® […]
Category: Press Releases
GenomeDx Biosciences to Present at Baird 2015 Healthcare Conference
San Diego, September 3, 2015 — GenomeDx Biosciences announced that it will present at the Baird 2015 Healthcare Conference on Thursday, September 10 at 3:10 p.m. ET in New York. Doug Dolginow, Chief Executive Officer, will provide an update about the company’s Decipher® test and an overview of the Company’s pipeline. About Decipher® The Decipher® […]
GenomeDx and Bostwick Laboratories Announce Marketing Agreement for Decipher Prostate Cancer Classifier Test
San Diego, CA, Uniondale, NY, October 4, 2016 – GenomeDx Biosciences and Bostwick Laboratories, Inc. today announced that Bostwick has entered into a marketing partnership agreement with GenomeDx, provider of the genomic Decipher® Prostate Cancer Classifier tests for men diagnosed with localized prostate cancer. Bostwick Laboratories is a national, full-service laboratory specializing in uropathology, and […]